Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-Kell in pregnancy.

H M Leggat1, J M Gibson, S L Barron

  • 1Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne.

British Journal of Obstetrics and Gynaecology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative corrections for fluctuation electron microscopy.

Journal of microscopy·2025
Same author

The change in glycaemic control immediately after the 3rd COVID-19 vaccination in people with type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2023
Same author

A precise measurement of the [Formula: see text] meson oscillation frequency.

The European physical journal. C, Particles and fields·2017
Same author

Fluctuation microscopy analysis of amorphous silicon models.

Ultramicroscopy·2017
Same author

Diagnosis of retinopathy in children younger than 12 years of age: implications for the diabetic eye screening guidelines in the UK.

Eye (London, England)·2016
Same author

Search for long-lived heavy charged particles using a ring imaging Cherenkov technique at LHCb.

The European physical journal. C, Particles and fields·2015
Same journal

Livial: an economic appraisal.

British journal of obstetrics and gynaecology·2000
Same journal

Livial: a review of clinical studies.

British journal of obstetrics and gynaecology·2000
Same journal

Place of birth and shoulder dystocia.

British journal of obstetrics and gynaecology·1999
Same journal

The value of the negative predictive values.

British journal of obstetrics and gynaecology·1999
Same journal

Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura.

British journal of obstetrics and gynaecology·1999
Same journal

Third trimester abortion: is compassion enough?

British journal of obstetrics and gynaecology·1999
See all related articles

Anti-Kell antibodies in pregnancy are less severe than previously thought, with most affected newborns surviving. Guidelines for Rhesus disease intervention may not be suitable for anti-Kell pregnancies.

Area of Science:

  • Immunology
  • Perinatal Medicine
  • Obstetrics

Background:

  • Haemolytic disease of the newborn (HDN) can arise from maternal antibody alloimmunization.
  • Anti-Kell antibodies are a known cause of HDN, but their clinical significance is debated.

Purpose of the Study:

  • To evaluate the severity and outcomes of pregnancies affected by anti-Kell antibodies.
  • To assess the applicability of existing Rhesus disease management guidelines to anti-Kell cases.

Main Methods:

  • Retrospective review of 194 pregnancies with anti-Kell antibodies as the sole detected antibody.
  • Analysis of neonatal outcomes, including severity of disease, survival, and stillbirths.
  • Correlation of anti-Kell antibody titers and amniotic fluid indices with disease severity.

Related Experiment Videos

Main Results:

  • Sixteen affected infants were born; none were hydropic, and three with severe disease survived.
  • Three stillbirths occurred, but none showed post-mortem signs of HDN.
  • High anti-Kell titers did not correlate with disease severity, and amniotic fluid predictions of stillbirth were often inaccurate.

Conclusions:

  • Haemolytic disease of the newborn caused by anti-Kell antibodies appears to be less severe than previously reported.
  • Current intervention guidelines based on Rhesus disease may be inappropriate for managing anti-Kell pregnancies.